Submit Deal

BIOCRYST PHARMACEUTICALS

HQ - Durham, North Carolina

Summary

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing novel, oral small-molecule and protein therapeutics for rare diseases.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 192 M

Avg. Deal Size£ 192 M

Market Context

Senior Management

Jon P. Stonehouse
President and CEO
Anthony Doyle
CFO

Sort

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

latham & watkins

HQ - New York, United States

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

skadden arps slate meagher & flom

HQ - New York

legal advisors (2)

2 Shared Deals

2 For

£ 192 M

Total Value

jp morgan

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

centerview partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 192 M

Total Value

white & case

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 192 M

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 For

£ 192 M

Total Value

td cowen

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 192 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy